Quinolone susceptibility of norA-disrupted Staphylococcus aureus

Antimicrobial Agents and Chemotherapy

Volumn 41, Issue 10, 1997, Pages 2308-2309

  Yamada, Hisashi ^a   Kurose Hamada, Sumiko ^a   Fukuda, Yoshiko ^a   Mitsuyama, Junichi ^a   Takahata, Masahiro ^a   Minami, Shinzaburo ^a   Watanabe, Yasuo ^a   Narita, Hirokazu ^a  

^a TOYAMA CHEMICAL CO LTD   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CIPROFLOXACIN; ENOXACIN; NORFLOXACIN; OFLOXACIN; PAZUFLOXACIN; QUINOLONE; SPARFLOXACIN; TOSUFLOXACIN;

ANTIMICROBIAL ACTIVITY; ARTICLE; CELL GROWTH; DRUG SENSITIVITY; GENE INSERTION; GENETIC CODE; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; MINIMUM INHIBITORY CONCENTRATION; PENICILLIN RESISTANCE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; STAPHYLOCOCCUS AUREUS;

EID: 0030840548     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.41.10.2308     Document Type: Article

References (14)

1. Ball, P. 1990. Emergent resistance to ciprofloxacin amongst Pseudomonas aeruginosa and Staphylococcus aureus: clinical significance and therapeutic approaches. J. Antimicrob. Chemother. 26(Suppl. F):165-179.
2. Chapman, J. S., and N. H. Geogopapadakou. 1988. Routes of quinolone permeation in Escherichia coli. Antimicrob. Agents Chemother. 32:438-442.
3. Coleman, D. C., I. Chopra, S. W. Shales, T. G. B. Howe, and T. J. Foster. 1983. Analysis of tetracycline resistance encoded by transposon Tn10: deletion mapping of tetracycline-sensitive point mutations and identification of two structural genes. J. Bacteriol. 153:921-929.
4. Ferrero, L., B. Cameron, B. Manse, D. Lagneaux, J. Crouzet, A. Famechon, and F. Blanche. 1994. Cloning and primary structure of Staphylococcus aureus DNA topoisomerase IV: a primary target of fluoroquinolone. Mol. Microbiol. 13:641-653.
5. Hooper, D. C., and J. S. Wolfson. 1991. Fluoroquinolone antimicrobial agents. N. Engl. J. Med. 324:384-394.
6. Japanese Society of Chemotherapy. 1981. Revision of methods for determining minimum inhibitory concentrations. Chemotherapy (Tokyo) 29:76-79.
7. Kaatz, G. W., S. M. Seo, and C. A. Ruble. 1993. Efflux-mediated fluoroquinolone resistance in Staphylococcus aureus. Antimicrob. Agents Chemother. 37:1086-1094.
8. Kaatz, G. W., S. M. Seo, and C. A. Ruble. 1990. Mechanisms of fluoroquinolone resistance in Staphylococcus aureus. J. Infect. Dis. 163:1080-1086.
9. Neyfakh, A. A. 1992. The multidrug efflux transporter of Bacillus subtilis is a structural and functional homolog of the Staphylococcus aureus NorA protein. Antimicrob. Agents Chemother. 36:484-485.
10. Takenouchi, T., F. Tabata, Y. Iwata, H. Hanzawa, M. Sugawara, and S. Ohya. 1996. Hydrophilicity of quinolones is not an exclusive factor for decreased activity in efflux-mediated resistant mutants of Staphylococcus aureus. Antimicrob. Agents Chemother. 40:1835-1842.
11. Trucksis, M., D. C. Hooper, and J. S. Wolfson. 1991. Emerging resistance to fluoroquinolones in staphylococci: an alert. Ann. Intern. Med. 114:424-426.
12. Ubukata, K., N. Itoh-Yamashita, and M. Konno. 1989. Cloning and expression of the norA gene for fluoroquinolone resistance in Staphylococcus aureus. Antimicrob. Agents Chemother. 33:1535-1539.
13. Ubukata, K., R. Nonoguchi, M. Matsuhashi, M. O. Song, and M. Konno. 1989. Restriction maps of the regions coding for methicillin and tobramycin resistances on chromosomal DNA in methicillin-resistant staphylococci. Antimicrob. Agents Chemother. 33:1624-1626.
14. Yoshida, H., M. Bogaki, S. Nakamura, K. Ubukata, and M. Konno. 1990. Nucleotide sequence and characterization of the Staphylococcus aureus norA gene, which confers resistance to quinolones. J. Bacteriol. 172:6942-6949.